Keyphrases
Age-related Osteoporosis
13%
Aging
15%
Antineoplastic Drugs
13%
ApoER2
14%
Aptamer
100%
Aptamer Targeting
13%
Binding Affinity
21%
BMP Signaling
27%
Bone Erosion
13%
Bone Formation
81%
Breast Cancer
22%
Breast Cancer Bone Metastasis
27%
Breast Cancer Patients
19%
Cancer Targeting
13%
Carcinoma
13%
Cardiovascular Protective
13%
Cardiovascular Risk
16%
Cas9 Protein
13%
Casein Kinase 2 Interacting protein-1 (CKIP-1)
13%
Cell-SELEX
13%
Chemical Modification
16%
Chemotherapy
14%
Deep Learning Methods
13%
Drug Discovery
27%
Extracellular Vesicles
13%
Gain Cell
13%
Gene Network
13%
Glucocorticoid-induced Osteoporosis
13%
Huaier Granule
13%
Hypoxia-inducible factor-1α (HIF-1α)
13%
Immune Checkpoint
13%
Immune System
13%
Immune-related
13%
In Cancer
20%
Inflammation
17%
Inflammatory Genes
13%
Inflammatory Process
13%
Inflammatory Response
15%
Interleukin-17 (IL-17)
13%
Joint Inflammation
13%
Leflunomide
13%
Lipopolymer
13%
MicroRNA
29%
Mini
15%
MiR-214-3p
13%
MiRNA-mRNA Interaction
13%
Molecular Therapeutics
13%
Molecular Understanding
27%
Mouse Model
15%
Nucleic Acid Aptamer
17%
Nucleic Acids
27%
Nucleocytoplasmic Shuttling
13%
Nucleolin Aptamer
13%
Oligonucleotides
15%
Osteoblast
33%
Osteoblastic
40%
Osteoclast
21%
Osteogenesis Imperfecta
20%
Osteolytic Metastasis
13%
Ovarian Cancer
13%
Paclitaxel
40%
Pancreatic Cancer
27%
Pancreatic Ductal Adenocarcinoma
27%
PARP Inhibitor (PARPi)
13%
PD-L1 Aptamers
13%
Phosphorus Metabolism
13%
Programmed Death-ligand 1 (PD-L1)
27%
Protective Behavior
17%
Rare Bone Disease
13%
Receptor Activator of nuclear factor-κB Ligand (RANKL)
13%
Rheumatoid Arthritis
27%
Sclerostin
95%
Sclerostin Inhibitor
14%
Shuttling Protein
13%
Single Center
13%
Smad
27%
Small Molecules
16%
Smurf1
15%
Structure Determination
13%
Systems-based
13%
Targeted Therapeutics
13%
Targeted Therapy
16%
Targeting Strategies
13%
Therapeutic Genome Editing
13%
Therapeutic Perspectives
13%
Therapeutic Strategies
23%
Therapeutic Target
21%
Therapeutic Use
20%
Triple-negative Breast Cancer
27%
Triple-negative Breast Cancer Cells
17%
Tumor
15%
Tumor Cells
17%
Tumor Metastasis
14%
Tumor Progression
18%
Tumor Targeting
16%
Vascular Endothelial
13%
Vascular Endothelial Growth Factor
13%
Vinorelbine
13%
Water-soluble
13%
Wnt Signaling
15%
Pharmacology, Toxicology and Pharmaceutical Science
Apolipoprotein E Knockout Mouse
8%
Aptamer
82%
Bone Disease
15%
Bone Erosion
13%
Bone Metastasis
27%
Breast Cancer
42%
Carcinoma
13%
Cardiovascular Risk
18%
Chemotherapy
14%
Clinical Trial
6%
Disease Free Survival
7%
Diseases
9%
Drug
13%
Drug Delivery System
5%
Drug Discovery
31%
Immunogenicity
6%
Immunotherapy
13%
Inflammation
17%
Inflammatory Arthritis
13%
Leflunomide
13%
Lung Cancer
13%
Lung Metastasis
5%
Malignant Neoplasm
25%
Messenger RNA
15%
Metastasis
16%
microRNA
19%
microRNA 214
13%
Monoclonal Antibody
15%
Mouse Model
5%
Nanoparticle
6%
Neoplasm
41%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
13%
Nucleic Acid
28%
Nucleolin
13%
Nude Mouse
5%
Osteoclast Differentiation Factor
13%
Osteogenesis Imperfecta
19%
Osteosarcoma
13%
Ovary Cancer
13%
Overall Survival
7%
Paclitaxel
27%
Pancreas Cancer
13%
Programmed Death 1 Ligand 1
13%
Receptor
5%
Retrospective Study
13%
Rheumatoid Arthritis
13%
Sclerostin
81%
Survival Rate
6%
Triple Negative Breast Cancer
13%
Tumor Growth
14%
Tumor Necrosis Factor Receptor Associated Factor 3
13%
Vasculotropin A
13%
Vinorelbine
13%
X-Linked Hypophosphatemia
5%
Medicine and Dentistry
Alpha 1 Antitrypsin
13%
Angiogenesis
5%
Aptamer
49%
Biological Marker
8%
Bone Metastasis
27%
Bone Morphogenetic Protein
13%
Bone Morphogenetic Protein 2
5%
Breast Cancer
40%
Cancer
7%
Cancer Associated Fibroblast
13%
Cancer Cell
7%
Cancer Therapy
6%
Carcinoma
13%
Cardiovascular System
17%
Cardiovascular System
5%
Cas9
13%
Chalcone Derivative
5%
Chemokine
13%
Chondrocyte
13%
Clustered Regularly Interspaced Short Palindromic Repeat
13%
Diagnosis
10%
Disease Free Survival
7%
Disorders of Calcium Metabolism
13%
Drug
13%
Fibroblast Growth Factor 23
6%
Genome Editing
13%
Hazard Ratio
7%
Isotopes of Calcium
6%
Lung Metastasis
5%
Metabolomics
13%
Metastatic Carcinoma
7%
microRNA
19%
microRNA 214
13%
Monoclonal Antibody
7%
Neoplasm
10%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
13%
Nucleic Acid
13%
Ossification
29%
Osteoarthritis
13%
Osteoclast
20%
Osteoclast Differentiation Factor
13%
Osteolysis
5%
Osteoporosis
13%
Osteosarcoma
13%
Overall Survival
7%
Paclitaxel
13%
Pancreas Adenocarcinoma
13%
Pancreas Cancer
13%
Parathyroid Hormone
6%
Phosphate Metabolism
13%
Programmed Death-Ligand 1
13%
Propensity Score Matching
13%
Proteomics
13%
Receptor
6%
Retrospective Study
13%
RNA Sequencing
8%
Sclerostin
27%
Secretion (Process)
5%
Spinal Fusion
5%
Survival Rate
6%
Targeted Therapy
17%
Triple Negative Breast Cancer
13%
Tumor Cell
14%
Tumor Microenvironment
11%
Tumor Necrosis Factor Receptor Associated Factor 3
13%
Vasculotropin A
13%